Brief: Avacta And Daewoong Establish Joint Venture

Daewoong Pharma

08/01/2020 07:51

Jan 8 (Reuters) - Avacta Group PLC  AVTG.L :
    * AVACTA AND DAEWOONG ESTABLISH JOINT VENTURE
    * COLLABORATION TO DEVELOP NEXT GENERATION CELL AND GENE
THERAPIES
INCORPORATING AFFIMER PROTEINS
    * TO ESTABLISH JV IN SOUTH KOREA WITH DAEWOONG
PHARMACEUTICAL FOR
COLLABORATION, LICENSE AGREEMENT
    * AVACTA'S SHAREHOLDING IN JOINT VENTURE IS 45%
    * JV TO BE OPERATIONALLY MANAGED BY SENG-HO JEON, CEO OF
DAEWOONG,
WITH A BOARD COMPOSED OF REPRESENTATIVES OF BOTH AVACTA AND
DAEWOONG

Source text for Eikon:  ID:nRSH1128Za 
Further company coverage:  AVTG.L 

 ((Reuters.Briefs@thomsonreuters.com;))